Status:
RECRUITING
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
Lead Sponsor:
University of Maryland St. Joseph Medical Center
Collaborating Sponsors:
Medical Metrics Diagnostics, Inc
Conditions:
Lumbar Spinal Fusion
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
A double blind prospective randomized trial of IV ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Eligibility Criteria
Inclusion
- 18-85 years old (inclusive)
- Elective posterior lumbar instrumented fusion
- One or two level fusion
- Consent to participate in study and willing to adhere to study follow up
- English proficiency
Exclusion
- \< 18 or \> 85 years old
- History of renal failure, dialysis, or creatinine over 1.50 mg/dl
- Active or recent smoker (active within past 6 months)
- Revision surgery
- Auto/worker compensation
- Active cancer or history of chemotherapy in past 6 months
- Active narcotic use within 3 months of surgery date
- Infection at operative levels
- Any allergies to NSAIDs or Opioids
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT06513208
Start Date
January 1 2026
End Date
June 1 2027
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland St. Joseph Medical Center
Towson, Maryland, United States, 21204